Pharmaceuticals news FT.com

Pfizer CEO ‘disappointed’ by Kennedy’s refusal to rebut claims on jab risks

Albert Bourla says Donald Trump’s nominee for health secretary still appeared to ‘temper’ some of his views

Feb 9, 2025 - 21:46
 0
Pfizer CEO ‘disappointed’ by Kennedy’s refusal to rebut claims on jab risks
Albert Bourla says Donald Trump’s nominee for health secretary still appeared to ‘temper’ some of his views
Read More

Tags:

Previous Article

GSK launches £2bn buyback on strong HIV and cancer drugs sales

Next Article

Merck shares sink 11% after vaccine shipments to China halted

Related Posts

New fund plans to buy up struggling listed biotechs

New fund plans to buy up struggling listed biotechs

Apr 18, 2025  0

Johnson and Johnson warns pharma tariffs could cause drug shortages

Johnson and Johnson warns pharma tariffs could cause dr...

Apr 15, 2025  0

Elliott held talks with private equity as it considered new Bayer campaign

Elliott held talks with private equity as it considered...

Mar 26, 2025  0